Course of Cerebral Infarction (Ischemic Stroke)
The typical course of cerebral infarction progresses through distinct temporal phases: hyperacute (0-24 hours), acute (1-7 days), subacute (7 days-3 weeks), and chronic (>3 weeks), each characterized by specific pathophysiological changes and clinical management priorities.
Hyperacute Phase (0-24 hours)
This is the most critical time-sensitive period where "Time is Brain"—every minute of delay results in loss of 1.9 million brain cells, 13.8 billion synapses, and 12 km of axonal fibers 1. The brain ages approximately 3.6 years for every hour without treatment 1.
Key Clinical Features:
- Neuronal injury begins immediately: Red hypoxic and "ghost" neurons appear, along with acute neuronal injury and spongiosis 2
- Blood pressure typically elevated: Up to 80% of patients present with hypertension, though BP often decreases spontaneously within 90 minutes 3
- Seizures may occur: Most likely within the first 24 hours if they develop, usually partial with or without secondary generalization 4
- Brain edema is minimal except in large cerebellar infarctions 4
Management Priorities:
- Immediate reperfusion therapy (IVT within 4.5 hours, EVT within 6-24 hours depending on imaging) 1
- Maintain oxygen saturation >94% only if hypoxic 5
- BP management: Keep <185/110 mm Hg before thrombolysis and <180/105 mm Hg for 24 hours after 5
Acute Phase (1-7 days)
Days 1-2:
Continued acute neuronal injury with red neurons and ghost cells predominating 2.
Days 3-7:
This is the critical period for cerebral edema, which peaks at 3-5 days post-stroke 4. Less than 10-20% of patients develop clinically significant edema requiring intervention 4.
Key Clinical Features:
- Acute inflammation phase begins (days 3-7): Coagulative necrosis with neutrophilic infiltrate 2
- Hemorrhagic transformation risk: Approximately 5% develop symptomatic hemorrhagic transformation spontaneously 4
- Infections emerge: Pneumonia is a leading cause of death; urinary tract infections occur commonly with secondary sepsis in ~5% 4
- Mass effect develops in large territorial infarcts, potentially causing herniation 6
Management Priorities:
- Admission to specialized stroke unit is mandatory 4—this single intervention improves mortality, independence, and home discharge at 1 year 5, 7
- Early mobilization to prevent complications 4
- DVT prophylaxis with subcutaneous anticoagulants or intermittent compression devices 4
- Aggressive infection surveillance and treatment 4
- For malignant edema: osmotherapy, hyperventilation, and surgical decompression for cerebellar infarcts 4
- Avoid corticosteroids—they are not recommended for cerebral edema 4
Subacute Phase (7 days - 3 weeks)
Days 10-37:
Chronic inflammation predominates with mononuclear and macrophage infiltrate, astrogliosis, spongiosis, and neovascularization 2.
Key Clinical Features:
- Edema begins resolving
- Macrophage infiltration peaks
- Astrocytic response intensifies
- Cavitation begins in larger infarcts
- Microglial activation persists even with small lesions 8
Management Priorities:
- Continue comprehensive rehabilitation 4
- Restart antihypertensive medications after first few days for secondary prevention 3
- Initiate antiplatelet therapy (aspirin) if not already started 4
- Screen for and treat post-stroke depression 4
- Nutritional support via nasogastric or PEG feeding if dysphagia persists 6
Chronic Phase (>3 weeks)
Weeks 3-8:
Characterized by absence of inflammatory reaction, presence of cavitation, astrogliosis, and persistent macrophages 2.
Months to Years:
Long-term pathological changes include:
- White matter deterioration and dysfunctional reorganization 9
- Progressive neurodegeneration 9
- Vascular remodeling 9
- Persistent neuroinflammation with chronic immune responses 9
Key Clinical Features:
- Cognitive impairment develops: >30% report persistent participation restrictions by 4 years 7
- Apathy affects >50% of survivors at 1 year 7
- Chronic fatigue is common and debilitating 7
- Depression remains highly prevalent 7
- Glial morphological changes persist even 19 days post-stroke with small lesions 8
Management Priorities:
- Long-term secondary prevention: Thiazide diuretic, ACE inhibitor, or ARB (or combination) 3
- BP goal <130/80 mm Hg may be reasonable 3
- Ongoing rehabilitation—stroke is a chronic condition requiring continued monitoring 7
- Address cognitive impairment, depression, and social reintegration 7
- Maintain physical activity and self-efficacy 7
Critical Prognostic Factors
Infarct growth rate (IGR) exhibits remarkable heterogeneity:
- Average IGR in large vessel occlusion: 5.4 mL/h 10
- Fast progressors (IGR ≥10 mL/h) have worse outcomes 10
- Lesion size at day 7 correlates with long-term microglial changes and outcomes 8
Common Pitfalls to Avoid
- Do not aggressively lower BP in acute phase unless >220/120 mm Hg or patient received thrombolysis 3, 5
- Avoid hypo-osmolar fluids (5% dextrose in water) as they worsen edema 4
- Do not use prophylactic anticonvulsants—no data support this practice 4
- Do not treat stroke as a transient condition—it requires chronic disease management 7
- Avoid indwelling bladder catheters when possible due to infection risk 4